XML 117 R39.htm IDEA: XBRL DOCUMENT v3.19.3
EMPLOYEE STOCK COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation Expense
The following table presents stock-based compensation expense and the related tax benefits for the periods indicated:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
($ in thousands)
 
2019
 
2018
 
2019
 
2018
Stock options
 
$
3

 
$
32

 
$
(13
)
 
$
145

Restricted stock awards and units
 
1,491

 
1,366

 
3,857

 
5,128

Total share-based compensation expense
 
$
1,494

 
$
1,398

 
$
3,844

 
$
5,273

Related tax benefits
 
$
439

 
$
410

 
$
1,130

 
$
1,546
Unrecognized Share-Based Compensation Expense
The following table presents unrecognized stock-based compensation expense as of September 30, 2019:
($ in thousands)
 
Unrecognized Expense
 
Weighted-Average Remaining Expected Recognition Period
Stock option awards
 
$
9

 
0.8 years
Restricted stock awards and restricted stock units
 
11,399

 
2.3 years
Total
 
$
11,408

 
2.3 years
Option Activity
The following table represents stock option activity for the three months ended September 30, 2019:
 
 
Three Months Ended September 30, 2019
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
135,521

 
$
13.65

 
5.1 years
 
 
Exercised
 
(73,000
)
 
$
13.47

 
5.6 years
 
 
Forfeited
 
—

 
$
—

 
0.0 years
 
 
Outstanding at end of period
 
62,521

 
$
13.85

 
4.6 years
 
$
18

Exercisable at end of period
 
59,149

 
$
13.86

 
4.5 years
 
$
17


The following table represents stock option activity for the nine months ended September 30, 2019:
 
 
Nine Months Ended September 30, 2019
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
186,973

 
$
13.54

 
5.8 years
 


Exercised
 
(74,836
)
 
$
13.41

 
5.2 years
 
 
Forfeited
 
(49,616
)
 
$
13.34

 
6.1 years
 


Outstanding at end of period
 
62,521

 
$
13.85

 
4.6 years
 
$
18

Exercisable at end of period
 
59,149

 
$
13.86

 
4.5 years
 
$
17
Nonvested Share
The following table sets forth information regarding unvested stock options for the three and nine months ended September 30, 2019:
 
 
Three Months Ended September 30, 2019
 
Nine Months Ended September 30, 2019
 
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Number of Shares
 
Weighted-Average
Exercise Price
Per Share
Outstanding at beginning of period
 
7,848

 
$
13.35

 
63,848

 
$
13.30

Vested
 
(4,476
)
 
$
13.05

 
(16,476
)
 
$
13.22

Forfeited
 
—

 
$
—

 
(44,000
)
 
$
13.29

Outstanding at end of period
 
3,372

 
$
13.75

 
3,372

 
$
13.75
Restricted Stock and Restricted Stock Units Activity The following table presents unvested restricted stock awards and restricted stock units
activity for the three and nine months ended September 30, 2019:
 
 
Three Months Ended September 30, 2019
 
Nine Months Ended September 30, 2019
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value Per Share
 
Number of Shares
 
Weighted
Average Grant
Date Fair Value
Per Share
Outstanding at beginning of period
 
1,106,854

 
$
15.93

 
833,601

 
$
19.02

Granted (1)
 
49,191

 
$
14.84

 
772,589

 
$
14.36

Vested (2)
 
(25,522
)
 
$
15.11

 
(240,779
)
 
$
18.54

Forfeited (3)
 
(63,512
)
 
$
16.62

 
(298,400
)
 
$
18.64

Outstanding at end of period
 
1,067,011

 
$
15.86

 
1,067,011

 
$
15.86


(1)
There were 23,540 and 174,935 performance-based shares/units included in shares granted for the three and nine months ended September 30, 2019, respectively.
(2)
There were 0 and 37,572 performance-based shares/units included in vested shares for the three and nine months ended September 30, 2019, respectively.
(3)
The number of forfeited shares includes aggregate performance-based shares/units of 28,617 and 171,150 for the three and nine months ended September 30, 2019, respectively.
Summary of all Outstanding SARs
The following table represents SARs activity and the weighted average exercise price per share as of and for the three months ended September 30, 2019:
 
 
Three Months Ended September 30, 2019
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
1,559,012

 
$
11.60

 
3.2 years
 
$
3,691

Outstanding at end of period
 
1,559,012

 
$
11.60

 
2.9 years
 
$
3,956

Exercisable at end of period
 
1,559,012

 
$
11.60

 
2.9 years
 
$
3,956


The following table represents SARs activity and the weighted average exercise price per share as of and for the nine months ended September 30, 2019:
 
 
Nine Months Ended September 30,
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
1,559,012

 
$
11.60

 
3.6 years
 
$
2,662

Outstanding at end of period
 
1,559,012

 
$
11.60

 
2.9 years
 
$
3,956

Exercisable at end of period
 
1,559,012

 
$
11.60

 
2.9 years
 
$
3,956